Defining the terminology of hip and groin pain in 2026: A scoping review of consensus statements

Purpose This scoping review summarizes the current consensus statements for classifying hip and groin pain in young and middle‐aged active individuals and evaluates their citation impact. Secondarily, it asseses to what extent they have been adopted in clinical practice. Methods An electronic database search was performed in September 2026 using PubMed, EMBASE and Google Scholar to identify all consensus statements outlining terminology for young and middle‐aged adults with hip or groin pain, and studies investigating the clinical adoption of proposed consensus terminology classifications. Citation counts were used to quantify citation impact, and survey data were used to evaluate clinical adoption. Results Nine consensus statements focusing on hip or groin pain in young and middle‐aged adults were identified. Four papers, focused on groin pain (different entities); the terminology recommended across these statements varied considerably. All four consensus papers on the hip joint recommend the term femoroacetabular impingement syndrome and there was considerable overlap. One recent multidisciplinary consensus proposed a unified five‐entity taxonomy spanning both hip joint and groin pain. The Warwick and Doha statements have been cited most frequently. The only study investigating clinical adoption found that clinicians and experts most commonly used the Doha agreement terminology in academic work and professional communication. Conclusion Consensus on the terminology and classification of hip and groin pain has evolved substantially over the past decade. Consensus statements for groin pain vary significantly in their focus (based on different entities), terminology and levels of detail for classifying patients. Greater agreement exists in the terminology and classification of hip joint‐related pain. Resolving these discrepancies is essential for consistent multidisciplinary communication, reliable research synthesis and for establishing clear clinical decision‐making guidelines for patients with hip and groin pain. Level of Evidence Level V.